by Eduardo Villarreal-Fernandez, Ravi Patel, Reshma
Golamari, Muhammad Khalid, Ami DeWaters and Philippe Haouzi
Critical Care volume 24,
Article number: 337 (2020)
Letter to the editor:
In early February 2020, Yang et al. [1] reported an alarming high mortality rate
in patients with COVID-19-associated acute respiratory failure requiring
mechanical ventilatory support. Such a dreadful outcome was regarded as the
fundamental tenet dictating our strategy to treat patients with COVID-19 acute
respiratory failure. Two essential recommendations were offered to the medical
community in keeping with these first reports: (1) early intubation of
hypoxemic patients [2]. Indeed, since a profound hypoxemia
appears to be the hallmark of COVID-19-associated pneumonia, the initial
consensus [2] was to start invasive mechanical
ventilation as soon as possible due to the overwhelming number of patients in
respiratory failure presenting at the same time in a hospital and to prevent
the risk of hypoxic cardiac arrest; (2) avoidance of high-flow nasal cannula
(HFNC) to reduce respiratory droplet aerosolization for healthcare workers [3] in what was seen as “inevitable”
intubations.
No comments:
Post a Comment